Quick infos Headquarters: Rockville, Maryland, United States Trade prices Volume: Market Cap: 29.52M Prev closed: 3.1 Open: 3.08 High: 3.11 Low: 2.86 52 week low: 2.34 52 week high: 5.19 Dividends: No Dividends Next ER: November 9, 2022 Before Market Opens
Company Profile GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need.
Earnings History Date EPS / Forecast Revenue / Forecast March 2, 2023 November 9, 2022 -0.16 / -0.25- / -August 3, 2022 -0.25 / -0.28575K / -Beat! May 5, 2022 - / -0.355- / -March 3, 2022 -0.33 / -0.342518K / -Beat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 3, 2022 0.717 0.710 0.718
0.673
151.54K 6.70% Aug 2, 2022 0.672 0.670 0.697
0.668
73.47K 0.30% Aug 1, 2022 0.670 0.667 0.698
0.660
74.56K 1.06% Jul 29, 2022 0.663 0.680 0.690
0.655
54.75K -1.92% Jul 28, 2022 0.676 0.725 0.725
0.674
45.08K -5.2% Jul 27, 2022 0.713 0.714 0.714
0.671
46.90K 3.35% Jul 26, 2022 0.690 0.678 0.715
0.678
39.42K 1.47% Jul 25, 2022 0.680 0.730 0.730
0.663
76.44K -5.03% Jul 22, 2022 0.716 0.730 0.752
0.710
68.36K -3.56% Jul 21, 2022 0.742 0.750 0.769
0.712
78.55K 1.70% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
GlycoMimetics (GLYC) Q4 2021 Earnings Call Transcript fool.com Nov 17, 2022 1:00 pm
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2022 finance.yahoo.com Nov 17, 2022 7:30 am
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2022 finance.yahoo.com Nov 17, 2022 7:00 am InMed, AirSculpt top healthcare gainers; BrainsWay, Brookdale among losers seekingalpha.com Nov 16, 2022 11:01 pm
Are Medical Stocks Lagging Axonics (AXNX) This Year? finance.yahoo.com Nov 16, 2022 9:40 am GlycoMimetics GAAP EPS of -$0.16 beats by $0.10 seekingalpha.com Nov 9, 2022 8:13 pm GlycoMimetics has a new Chief Medical Officer seekingalpha.com Sep 6, 2022 7:10 pm
Insiders at GlycoMimetics, Inc. (NASDAQ:GLYC) recouped some losses this week after buying this year, still down US$49k finance.yahoo.com Nov 10, 2022 9:12 am
GlycoMimetics to Participate in Two Upcoming Investor Conferences finance.yahoo.com Nov 8, 2022 4:05 pm
GlycoMimetics to Report Third Quarter Financial Results on November 9, 2022 finance.yahoo.com Nov 2, 2022 7:00 am
GlycoMimetics (GLYC) Upgraded to Buy: Here's Why finance.yahoo.com Oct 4, 2022 12:00 pm
GlycoMimetics to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference finance.yahoo.com Sep 7, 2022 7:00 am
What Makes GlycoMimetics (GLYC) a New Buy Stock finance.yahoo.com Aug 9, 2022 12:00 pm GlycoMimetics GAAP EPS of $0.25 beats by $0.53, revenue of $75K seekingalpha.com Aug 3, 2022 7:14 pm
Here's Why GlycoMimetics (NASDAQ:GLYC) Must Use Its Cash Wisely finance.yahoo.com Jul 18, 2022 10:22 am
GlycoMimetics to Participate at Upcoming Jefferies 2022 Healthcare Conference finance.yahoo.com Jun 2, 2022 4:00 pm GlycoMimetics GAAP EPS of -$0.28 beats by $0.03 seekingalpha.com Apr 28, 2022 7:43 pm GlycoMimetics Q1 2022 Earnings Preview seekingalpha.com Apr 28, 2022 12:48 am
GlycoMimetics to Participate at Upcoming Roth Investor Conference finance.yahoo.com Mar 8, 2022 4:30 pm GlycoMimetics files for $250M mixed shelf offering seekingalpha.com Mar 5, 2022 5:23 am This company doesn't provide a dividend.
Talk about GlycoMimetics below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.